CHMP fandt grund til betænkelighed ved, at det ikke var muligt at fastslå fordelene ved de behandlingskombinationer, der omfattede Taxotere/ Docetaxel Winthrop som supplement til kirurgi, på grund af udformningen af den eneste hovedundersøgelse.
The CHMP was concerned that it was not possible to establish the benefits of the treatment combinations including Taxotere/ Docetaxel Winthrop when used in addition to surgery, because of the way the single main study was designed.